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Abstract
Multiple organ dysfunction syndrome (MODS) has an incidence rate of between
11 to 56% in the PICU. Early prevention and treatment of MODS is important in
the pediatric population as it increases mortality and leads to possible negative
functional outcomes in adulthood. MODS severity is measured using a few
different metrics, among which the Pediatric Logistic Organ Dysfunction 2 Score
(PELOD-2) is the most recent, pediatric multi-center validated scoring system.
This study attempted to build a generalized linear model to detect risk of PICU
patients at Johns Hopkins Children’s Center from a retrospectively gathered
cohort, using PELOD-2 Score≥6 to define MODS severity and minute to minute
physiological data as model covariates. Patient specific models were built with
a two hour window for transitioning into severe state, the positive class, and the
non-severe state was undersampled to balance classes. A global model was built
across the majority of the patient population with similar parameters in order
to create a more useful, clinical applicable model. The accuracy, sensitivity, and
specificity of training and testing sets were calculated for each model. Patient
specific models performed well, but performance decayed for the global model,
where predictions at the patient level for risk of transitioning had high sensitivity
and very low specificity. Future research should continue to refine the definition
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of a severe state of MODS and calibrate the sampling scheme with regards to
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Early detection of severity of organ failure is important in the prevention of
negative outcomes in critically ill children in the Pediatric Intensive Care Unit
(PICU). Multiple organ dysfunction syndrome (MODS) has a reported inci-
dence rate of 11-56% in the PICU [1, 2], and is associated with mortality rates
ranging from 11-57% [3, 4]. The prevalence of MODS and its characteristic as
a continuum of decaying physiology lend it to be a valuable target for study.
In the pediatric population, the Pediatric Multiple Organ Dysfunction Score
(P-MODS), the Pediatric Logistic Organ Dysfunction (PELOD) score, the more
recent PELOD-2 score were designed to predict mortality in children with
MODS [5, 6, 7, 4]. P-MODS uses lactic acid, PaO2/FiO2, Bilirubin, Fibrinogen,
and Blood Urea Nitrogen values to determine the point based severity of organ
dysfunction in the cardiovascular, respiratory, hepatic, hematologic, and renal
systems respectively. The state of each system is represented by the measure-
ment of one variable. The Glasgow Coma Score (GCS) and neurological system
was considered to have too many factors affecting availability of reliable mea-
surement due to patients on sedation or neuromuscular blockade drugs, and was
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excluded from the P-MODS score [6]. All of these scores are normally calcu-
lated infrequently in practice, and often only at a 24 hour interval for research
purposes.
The PELOD score has been validated at multiple PICUs, and has been
shown to be suitable for use in assessing pediatric morbidity due to MODS
across multiple hospital centers [4]. The score covers the neurological, cardio-
vascular, renal, respiratory, hematological, and hepatic systems assigning sever-
ity points in each organ system across the variables GCS, pupillary reactions,
heart rate, systolic blood pressure, creatinine, PaO2/FiO2, PaCO2, mechanical
ventilation, white blood cell count, platelets, aspartate transaminase, and pro-
thrombin time. In Leteurtre et al. [8], the PELOD-2 score was developed as
an updated version of the original PELOD score that overcame the limitation
of non-continuous scoring. The PELOD-2 score also assigned points of severity
to each organ system, but calculated probability of mortality based on the sum
of severity points across all organ systems. PELOD-2 incorporates mean arte-
rial pressure and lactatemia, similar to the Sequential Organ Failure Assessment
(SOFA) in adults by Knaus et al. [9] and P-MODS scores, as opposed to systolic
blood pressure and heart rate in the scoring of cardiovascular organ dysfunction.
Hepatic dysfunction was left out of PELOD-2 because it contributed very little
to variance in performance and prediction of death [8, 10].
It is important to note that these scores were created for use as an outcome
measure, and reflect the state of patients at the time that their samples were
collected for laboratory testing in relation to probability of mortality. Thus,
score rates are captured infrequently as a reflection that several variables are
only available after clinician deems that a patient is unhealthy and need blood
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sampling for laboratory measurements to be taken. The current scoring methods
were not designed to predict if a patient was at risk for further progressing into
increasingly severe states of organ dysfunction. These pediatric scoring systems
were originally based on adult scoring systems for calculating risk scores related
to adult mortality, such as the Acute Physiology and Chronic Health Evaluation
(APACHE) II and Sequential Organ Failure Assessment (SOFA) [11, 9, 10].
Predicting mortality may be important in adult populations due to their
higher mortality rates (29.1% in [12]) related to MODS than in children (5.0%,
6%, and 18.5% in [13, 4, 14]). (The upper limit to the above reported range of
pediatric related MODS mortality of 57% comes from an evaluation of PICU
standard of care in Malaysia [3]; in more developed countries, the mortality rate
is commonly at least three fold lower.) However, pediatric patients who survive
MODS are likely to have negative functional outcomes that affect later quality
of life and cause long term impairment [15]. Additionally, the progression of
MODS occurs more rapidly in children compared to adults [2, 16, 1, 17], with
maximum organ failure occurring within 24 h in almost 80% of patients who
develop MODS in the PICU [15]. Jaramillo-Bustamante et al. [18] observed that
45.1% of children were admitted to the PICU already in MODS. This study was
conducted in Colombia and admits that patients were probably admitted late
because of having to transport patients from more remote areas cities containing
specialized care resources. In areas where specialized medical care is more widely
accessible, it is therefore important to seek measures that predict the early stages
of organ failure and risk of developing MODS itself instead of mortality in PICU
populations.
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Early treatment has been shown to improve patient outcomes in several stud-
ies on sepsis, one of the most common causes of MODS in critically ill patients
[19, 14]. It is well known that adequate fluid resuscitation and appropriate ad-
ministration of antibiotics are associated with septic shock prevention and lower
mortality in sepsis patients [14, 20]. MODS and sepsis occur in overlapping pa-
tient populations [16, 21, 22] and are both characterized by a continual illness
progression [22, 23]. Both syndromes also happen to be scored in severity by
several of the same physiological variables. SOFA is calculated from PaO2/FiO2,
platelet count, GCS, mean arterial pressure, administration of vasopressors, and
creatinine. All of these variables are used in either the PELOD-2 score or P-
MODS with the exception of administration of vasopressors. The success of
early treatment in sepsis may be similarly replicated in patients with MODS if
the progression is detected and mitigated earlier as well.
Early detection has been been studied at multiple levels of treatment centers
at various stages of syndrome progression. The SOFA score, used in both adult
MODS and sepsis, has been shown to be a good predictor of early risk for septic
patients in Innocenti et al. [11]. SOFA score was calculated on admission to the
emergency department high dependency unit and after 24 hours. The 24 hour
score was significantly higher in patients who where subsequently transferred to
the ICU. While the AUC value of 0.8 was reported in this study, sensitivity and
specificity values were not specifically annotated and were around 75% for both
values interpreted from the ROC curve. Ghanem-Zoubi et al. [24] assessed the
prognostic value of the Rapid Emergency Medicine Score (REMS) on mortal-
ity in adults admitted to the general internal medicine department with sepsis.
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REMS is based on measurements of age, heart rate, temperature, mean arte-
rial pressure, respiratory rate, peripheral oxygen saturation, and GCS. Many
of these physiological parameters overlap with those important in diagnosing
MODS. The aptitude of the REMS score to distinguishing survivors from non-
survivors was evaluated through the ROC curve, and revealed an acceptable
AUC value of 0.79, sensitivity of around 75% and specificity around 70% (val-
ues were read off the ROC curve and not exact). However, both Innocenti et al.
[11] and Ghanem-Zoubi et al. [24] studied the adult population, and patients
with sepsis instead of MODS.
Sweney et al. [25] observed the predictive performance of the pediatric mod-
ified sequential organ failure assessment score (M-SOFA) on anticipating if pa-
tients required physician intervention in a PICU population compared to the de-
cision of trained clinicians retrospectively evaluating patients’ transport records
and hospital medical charts. The M-SOFA modifies SOFA score thresholds
across each variable to match pediatric age relevant thresholds. M-SOFA was
calculated from the first laboratory measurement, and if no measurement was
obtained within 6 hours of admission, they were assumed to be normal. Varying
the threshold of M-SOFA score produced a ROC curve where the best sensi-
tivity and specificity did not outperform physician triage. The results of this
study assumed that all of the actual decisions that were made regarding patients
needing to receive medical intervention were ground truth. A secondary out-
come was evaluated by correlating M-SOFA with the pediatric risk of mortality
III (PRISM-III) score, a validated mortality predictor [26], which revealed no
significant correlation between M-SOFA scores and PRISM-III. M-SOFA did
provide a high sensitivity (100%) and specificity (87%) in predicting mortality
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following cardiac surgery in neonates [27], but this result was based solely on a
population where all patients have cardiac related comorbidities.
There exists a gap in studies that predict the risk of negative prognoses that
include worsening outcomes that occur before death in the pediatric population.
Furthermore, all of the above mentioned methods of prediction rely on measure-
ments taken fixed windows. This disregards the continuous nature of MODS
and information from physiology that may be gleaned within a pre-determined
window where scoring occurs. One attempt to bridge this gap is the study by
Sandri et al. [28], in which investigators built Bayesian Networks to predict the
probability of sequential organ failure. The SOFA score was used to identify
organ dysfunction across the respiratory, cardiovascular, hepatic, renal, neuro-
logical, and hematologic systems in 24 hour time slices. A dynamic Bayesian
Network was trained with nodes representing up to three concurrent organ fail-
ures. This Bayesian approach revealed probabilities of day by day sequences of
organ failures starting from admission into the ICU. Accuracy of predicting the
three organ failure nodes was 71.62%, 75.54%, and 74.95%. Although this study
does focus on predicting the sequence of organ failures instead of mortality, the
time slices were still 24 h, a very long time in the scope of quickly evolving
pediatric organ dysfunction. Additionally, the nature of the Bayesian model
does not reveal information on the underlying physiology of why the sequence
of organ failures has the probability to progress in the way the model results
present.
Considering that the current research in MODS has not offered a satisfac-
tory predictor of early risk indicators, and that studies have mostly used large
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time windows, there exists a need for deeper examination of the features signifi-
cant in pre-organ failure state. Further elucidation of the physiological variables
relating to early organ failure states may also provide targets for timely inter-
vention. This study intends to create a model for risk of developing multiple
organ failure in the PICU, using data from the pre-organ failure state. The aim
of this thesis is to detect early that a patient at risk of entering into a severe
organ failure state will make this transition by: defining acceptable detection
criteria for a severe state, building a generalized linear model using physiological
time series data based on this criteria, and evaluating the performance of the





Electronic Health Record (EHR) data was acquired from Allscripts Sunrise/POE,
and minute to minute physiological data was acquired from HL7 exports of GE
Aware Gateways. Data contained 2711 PICU admissions of patients at Johns
Hopkins Children’s Center between July 2014 to October 2015. Only the first
PICU admission was used in the case of patients with multiple admissions [30].
Demographic information of all first PICU admissions is in Table 2.1.
This study was approved by the Johns Hopkins University School of Medicine
Institutional Review Board.
2.2 Patient Selection
The overall patient selection criteria are shown in Figure 2.1. The first two
blocks are related to data processing, and the latter blocks refer to patient


































≤30 days 95 (3.78%) 89 (3.59%) 6 (18.75%) <.0001
30 days <age <12 mo 421 (16.76%) 414 (16.69%) 7 (21.88%) 0.4358
12 mo ≤ age <12 yr 1334 (53.11%) 1319 (53.19%) 15 (46.88%) 0.4774
12 yr ≤ age <18 yr 662 (26.35%) 658 (26.53%) 4 (12.50%) 0.0735
Gender (0=Female) 1371 (54.58%) 1357 (54.72%) 14 (43.75%) 0.2158
Race
White 1148 (45.70%) 1132 (45.65%) 16 (50.00%) 0.6233
Black/African Am 856 (34.08%) 847 (34.15%) 9 (28.13%) 0.4749
Asian 114 (4.54%) 112 (4.52%) 2 (6.25%) 0.6398
Hawaiian/Pacific Is 3 (0.12%) 3 (0.12%) 0 (0.00%) 0.8440
Am Ind/Alaska Native 4 (0.16%) 4 (0.16%) 0 (0.00%) 0.8202
Multi Racial 12 (0.48%) 12 (0.48%) 0 (0.00%) 0.6934
All Other Races 274 (10.91%) 271 (10.93%) 3 (9.38%) 0.7797
Unknown 96 (3.82%) 94 (3.79%) 2 (6.25%) 0.4710
Decline to Answer 5 (0.20%) 5 (0.20%) 0 (0.00%) 0.7994
Trauma/Drowning 7 (0.28%) 7 (0.28%) 0 (0.00%) 0.7636
Operative Cardiac - Neonatal 2 (0.08%) 2 (0.08%) 0 (0.00%) 0.0539
Operative Cardiac - Pediatric 17 (0.68%) 16 (0.65%) 1 (3.13%) 0.0539
Non-operative Cardiac - Neonatal 57 (2.27%) 51 (2.06%) 6 (18.75%) 0.0006
Non-operative Cardiac - Pediatric 893 (35.55%) 875 (35.28%) 18 (56.25%) 0.0006
Respiratory - Neonatal 125 (4.98%) 120 (4.84%) 5 (15.63%) 0.0053
Respiratory - Pediatric 928 (36.94%) 915 (36.90%) 13 (40.63%) 0.6642
Non-Cardiac - Neonatal 38 (1.51%) 38 (1.53%) 0 (0.00%) 0.0006
Non-Cardiac - Pediatric 1522 (60.59%) 1514 (61.05%) 8 (25.00%) 0.0006
Mechanical Ventilation 649 (25.84%) 622 (25.08%) 27 (84.38%) <.0001
Non-Invasive Ventilation 940 (37.42%) 918 (37.02%) 22 (68.75%) 0.0002
ECMO 27 (1.07%) 17 (0.69%) 10 (31.25%) <.0001
Hemofiltration 28 (1.11%) 21 (0.85%) 7 (21.88%) <.0001
Peritoneal Dialysis 16 (0.64%) 15 (0.60%) 1 (3.13%) 0.0750
RBC Transfusion 294 (11.70%) 284 (11.45%) 10 (31.25%) 0.0005
Plasma Transfusion 7 (0.28%) 6 (0.24%) 1 (3.13%) 0.0021
Platlet Transfusion 65 (2.59%) 58 (2.34%) 7 (21.88%) <.0001
Pneumonia 368 (14.65%) 360 (14.52%) 8 (25.00%) 0.0957
Ventilator assisted Pneumonia 8 (0.32%) 8 (0.32%) 0 (0.00%) 0.7477
ARDS 495 (19.71%) 476 (19.19%) 19 (59.38%) <.0001
Sepsis 239 (9.51%) 228 (9.19%) 11 (34.38%) <.0001
Renal Insufficiency 118 (4.70%) 111 (4.48%) 7 (21.88%) <.0001
Cerebral Hemorrhage/Ischemia 21 (0.84%) 21 (0.85%) 0 (0.00%) 0.6013
Seizure 120 (4.78%) 117 (4.72%) 3 (9.38%) 0.2199
TBI 81 (3.22%) 79 (3.19%) 2 (6.25%) 0.3297
Cardiac Arrest 67 (2.67%) 49 (1.98%) 18 (56.25%) <.0001
Neuromuscular ˆ 307 (12.22%) 303 (12.22%) 4 (12.50%) 0.9614
Cardiovascular ˆ 636 (25.32%) 622 (25.08%) 14 (43.75%) 0.0158
Respiratory ˆ 194 (7.72%) 193 (7.78%) 1 (3.13%) 0.3270
Renal ˆ 64 (2.55%) 64 (2.58%) 0 (0.00%) 0.3575
Gastro ˆ 37 (1.47%) 37 (1.49%) 0 (0.00%) 0.4866
Heme/immune ˆ 23 (0.92%) 23 (0.93%) 0 (0.00%) 0.5844
Metabolic ˆ 261 (10.39%) 258 (10.40%) 3 (9.38%) 0.8498
Congenital/Genetic ˆ 430 (17.12%) 427 (17.22%) 3 (9.38%) 0.2420
Malignancy ˆ 213 (8.48%) 212 (8.55%) 1 (3.13%) 0.2740
Table 2.1: Patient Demographics Demographic information of the 2512 first
PICU admissions after initial patient selection. ˆ denotes categories defined by
Feudtner et al. [29]
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2210 Total Hospital Admissions
2711 Total PICU admissions
N (%) Excluded for:
163 (6.01%) Age >18 years at PICU admission
21 (0.77%) Do not have Heart Rate data available
17 (0.63%) Do not have Heart Rate records
8 (<.001%) Cancelled admission indicated by absence of discharge time
1 (<.001%) Missing room assignment
2 (<.001%) Admitted to PICU prior to study period
2656 PICU admissions
21 (0.77%) failed to find EHR and minute to minute data match
Use first PICU admissions only
2512 PICU admissions
Apply transition definition
1877 PICU admissions always
below transition threshold
137 PICU admissions with transition
Figure 2.1: Patient selection process
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Figure 2.2: Patient Progression for a patient who enters severe state
2.3 Patient Severity using PELOD-2 Score
The criteria used for measuring severity of organ failures was the PELOD-2
score based on the Leteurtre et al. [8] definition. However, instead of a daily
PELOD score, the PELOD-2 score was calculated in a rolling window. At any
time point, the worse measurement in each variable across the previous available
time up to 24 hours was used to calculate the score. Missing variables before
any value became available were assumed to be normal, adding no points to
the score [15]. Values were held for up to 24 hours before they were considered
missing again. Further details of data processing EHR data are described in the
Appendix 5.2.1.
In order to detect a patient at risk of entering some severe state before the
state occured, the model was built using data from patients who are initially
healthy before they become unhealthy. The progression of becoming worse was
split into two windows of interest: 1) the time where a patient was assumed to
be healthy, the non-transitional time and 2) the period before the severe state
occured, the transitional window (Fig 2.2).
Here, we start by defining the clinically relevant mark of severe organ dys-
function onset, which was the end of the transitional window. The top portion
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of Figure 2.3 may be used as an illustrated example of a patient initially rel-
atively healthy, and has a progressively increasing PELOD-2 score. According
to the Leteurtre PELOD-2 score, organ dysfunction occurs in each individual
organ when the score for variables contributing to one organ is non-zero [8].
This means that a PELOD-2 score of 1 point in Glasgow Coma Score and 1
point in Lactatemia denotes a patient with multiple organ dysfunction, but a
patient with PELOD-2 score of 6 points in mean arterial pressure has only sin-
gle organ dysfunction. In order to create a more continuous scaling of severity,
a PELOD-2 score strictly greater than 5 was used to define the transition into
a severe clinical state. This score threshold only occurs if a patient either has a
very severe score in the cardiovascular associated variable(s), or a combination
of two or more organ dysfunctions. In all of the following sections, the crossing
of this score threshold will be referred to as the transition, and the time at
which this occurs in a patient will be referred to as the transition time.
However, PELOD-2 score alone was not a certain enough to strictly mark
a transition. The infrequent capture of variables used to calculate PELOD-2
score created a level of uncertainty in regards to knowing when the transition
truly occured. In a sparsely sampled variable such as white blood cell count,
a transition could occur anywhere from an hour to some time over 24 hours
prior to the recording of a measurement value. After examining the frequency
of measurement in each variable contributing to PELOD-2 score (example in
Appendix 5.1), only transitions caused by mean arterial pressure and presence of
invasive ventilation were counted as trusted transitions, t = Ti, time of transition
in patient i, for modeling.
Taking into consideration that maximum pediatric MODS typically occurs
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within the first day of admission [15], that this model was concerned with the
period even before maximum severity, and that the median transition time
of this study cohort was 2.77 hours after PICU admission, the start of the
transitioning window was assigned at 120 minutes before Ti. The maximum
number of samples labeled yi(t) = 1 was 120 per patient. It was assumed that
the physiology of patients who never crossed the score threshold was in a similar
to that of the physiology of the earlier, non-transitional period in patients who
did eventually transition. The window of non-transitional time for patients who
transition is described in further detail under later sections. Distributions of
PELOD-2 Score and organ failure in the patients whose first transitions met the
critera described above and those who remained below threshold for the entire
PICU stay are shown in Table 2.2.
2.4 Minute to Minute Data Processing
Minute to minute data was collected, containing 6 physiological variables from
bedside physiological monitors. For mean arterial blood pressure, systolic blood
pressure, and diastolic blood pressure, the non-invasive cuff pressure was used
first, and if at any minute cuff pressure was missing, then the arterial pressure
was used if available.
Spike outliers were detected across each variable separately using the MAT-
LAB algorithm for median average deviation:
Median Absolute Deviation = median(|xi(t)−median(xi(outlier detection window))|)
(2.1)
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where xi(t) was a single measurement for patient i at time t and xi was
the vector of measurements for one variable during a specific outlier detection
window. Patient data was split into 2 hour outlier detection windows where
the first window began at onset of data, and each subsequent window began 30
minutes after the onset of the previous window to ensure smoothness, until the
end of patient data. Values over 3 median average deviations away from the
median were counted as outliers. Approximately 10% of patients were randomly
chosen to be validated by a clinician to ensure correct window size. Identified
outliers were filled using linear interpolation between the previous and next
available non-outlier values, and up to 15 minutes of values were replaced.
2.5 Data and Patient Matching
The minute to minute data contained hand entered partial names collected by
nurses at the bedside and lacked medical record number (MRN) identifiers,
so they were matched to EHR data using room number and time using the
following matching rules. It was assumed that one patient would take longer
than a minute to switch rooms, so continuous minute to minute recordings were
taken as one segment for one patient, and gaps in monitor recording longer than
a minute in length were taken as the possible start of a segment belonging to
new patient. Each identified segment was matched by endpoints to the segments
in the EHR vital signs data, which contained known MRNs. Minute to minute
segments with endpoints straddling the room and time of more than one MRN
were completely discarded.
Unique manually entered names identified minute to minute segments where
15
multiple streams of data were sometimes recorded in the same room. Although
the manually entered names were unreliable, these segments were discarded as
we couldn’t verify which data stream represented the true patient in the room.
Segments where there were no manually entered names were kept, but due
to the existence of the multiple stream data problem, they may need further
examination.
2.6 Generalized Linear Model Setup
All models constructed from data fell into the class of Generalized Linear Models
(GLMs) and in combination with a thresholding rule, classified each patient as
having a risk of transitioning into MODS or not. The GLM for a Bernoulli
response variable assumes that at any given minute, a patient’s state was a
Bernoulli random variable, where probability of being in the transitional state
was related to a linear combination of patient features[31].
The state of patient i at time t was defined as yi(t). When yi(t) = 1, at
this time t, patient i was in the transitional window before the severe state of
interest. yi(t) = 0 signified the opposite, where at time t, patient i was non-
transitional. y was the vector of class labels. For each of these time samples,
there was a corresponding feature vector Xi(t) containing the physiological data
at time t.
The probability that patient i at time t was in the transitional state was
defined as pi(t) = g(Xi(t)), where pi(t) was dependent on a function g operat-
ing on Xi(t), the feature vector of patient i at time t. For a binary outcome
regression, g is the logit function, which constrained the probability of positive
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class outcome P (y(t) = 1) between 0 and 1. The negative class was similarly
constrained by definition of being P (y(t) = 0) = 1 − P (y(t) = 1). Thus, the
probability that any patient was in the transitional state at time t was defined
as
P (y(t) = 1) ≜ p(t) ≜ g(X(t), β) = e
βT X(t)
1 + eβT X(t)
(2.2)
Using the maximum-likelihood estimation procedure, the optimal set of co-
efficients, β, was found by taking the product of probabilities across time in
a designated training sample, and maximizing this likelihood function with re-
spect to β.
The magnitude and sign of each coefficient resulting from GLM estimation
contains potentially clinically meaningful value. For example, since each feature
in this model was normalized to a mean of 0 and standard deviation of 1 (de-
scribed further below), a large positive value coefficient may suggest that the
corresponding feature has a large contribution to predicting a patient’s transi-
tion into MODS.
2.6.1 Patient Specific Modeling
Single patient modeling was used to confirm the rationale behind using a GLM
to classify patients transitioning into individualualized severe states of organ
dysfunction at an overtrained level. 31 GLMs were built for 31 patients after
the selection process and data availability considerations, further discussed in
results.
Class Labeling Scheme The transitioning window, began at t = Ti −
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120 minutes, and all samples before this time were labeled as non-transitional
(Fig 2.3).
yi(t) =
⎧⎨⎩0 if t0 ≤ t < Ti − 1201 if Ti − 120 ≤ t < Ti (2.3)
where t0 began at patient admission to PICU or whenever minute to minute
data first becames available following PICU admission.
Sampling and Bootstrap For each bootstrapping iteration, each patient
was sub-sampled uniformly at random within yi = 0 and yi = 1 class labels into
85/15% training and testing data respectively. After being split into training
and testing sets, each feature was normalized to a mean of 0 and standard
deviation of 1. In the training set, classes were balanced in each patient by
further subsampling the class with more samples to the same length as the
class with less samples. The MATLAB glmfit function was used to fit the final
training set of patients where the resulting number of samples was greater or
equal to 90% times number of features plus one (for the constant term), or ≥
63 samples.
P (yi(t) = 1) ≜ pi(t) ≜ g(Xi(t), βi) =
eβi
T Xi(t)
1 + eβiT Xi(t)
(2.4)
Since this model setup was only being used to substantiate the global pop-
ulation model, only 5 bootstrapping iterations were built per patient.
The 15% of data in each patient was used for testing was not sub-sampled.
Evaluation The criteria for detecting that a patient was at risk of transition-
ing into severe state per iteration was determined using the decision threshold,
τi, maximizing sensitivity and specificity on the ROC curve. This is the point















Figure 2.3: GLM Labels for Patient Specific Model 1a) Possible PELOD-
2 Score of a patient. The blue vertical lines mark the crossing the threshold for
transition at t = T , and the start of the period labeled as transitioning for the
GLM at t = T − 2 1b) Representation of the evolution of an arbitrary feature
during the times of interest. The horizontal arrows show the GLM labels in
their correct time periods.
was calculated for the training and testing set of each iteration and compared
to the decision threshold at each minute.
ŷi(t) =
⎧⎨⎩0 if p̂i(t) < τi1 if p̂i(t) ≥ τi (2.5)
To observe model performance at each iteration, both training and testing
sets were evaluated for accuracy, sensitivity, and specificity of their ŷi labels
across samples. Early detection time, T̂i, was defined as the first time the
estimated probability of a patient crossed the decision threshold.
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2.6.2 Global Population Modeling
In the model for the global population, patients were pooled together to create
one general model. Patients who never transitioned were incorporated as well.
In addition to the 6 features from minute-to-minute data used to build the
patient specific GLM, indicator features were added to represent age group and
gender in the global population model. The constant parameter in MATLAB
glmfit was turned off as it was represented in the combination of these indicator
features, which are constant per patient.
Labeling Scheme Let patients who contain trustable transitions be de-
noted as the subset i1, and patients who never transition to the severe state
be denoted as i0. The class sampling windows used the same definition of
a transitional state and the same window length of transitional state as the
patient specific model, but incorporated a 120 minute zero-sampling window
prior to the transitional state to account for possible differences in the unknown
physiology during the very early transitioning time or possible instability in pa-
tient physiology after PICU admission. The no-sampling window spanned from
t = Ti1 −240 minutes to t = Ti1 −120 minutes. The non-transitional time began
from first available data following PICU admission to 240 minutes prior to Ti1 .
Thus, patients who transition follow this labeling scheme
yi1(t) =
⎧⎪⎪⎪⎨⎪⎪⎪⎩
0 if t0 ≤ t < Ti1 − 240
NaN if Ti1 − 240 ≤ t < Ti1 − 240
1 if t ≤ Ti1
(2.6)
while patients who never transition are labeled yi0(t) = 0∀t. In patients who













TT − 2T − 4
TT − 2T − 4
t0
t0
yi1 = 0 yi1 = 1
yi0 = 0
Figure 2.4: GLM Labels for Global Model when patient i1 has sufficient
yi = 0 data available. 2a) Possible PELOD-2 Score of patient i1 with blue
vertical lines marking t = T as the time of transition, t = T − 2 hours, and
t = T − 4 hours the boundaries of the no sampling region, 2b) An example
of a model feature overlaid with the GLM labels and a gray box depicting the
nosampling region. 2c-d) The possible PELOD-2 Score and single feature of a























Figure 2.5: GLM Labels for Global Model when patient i1 does not have
sufficient yi1 = 0 data available. 3a) Possible PELOD-2 Score of a patient
i1 where they are admitted and undergo first transition within 4 hours, 2b)
Example of patient GLM label when there is less than 4 hours of data before
transition 3c and e) Example PELOD-2 Scores of age group and gender matched
i0 patients, 3d and f) Example feature values in the two i0 patients where y = 0
data is sampled from
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Bootstrap 50 iterations were used for bootstrapping. In each iteration,
80% of patients containing transitions were use for training, and the remaining
20% for testing. The i0 patients were split according to the sampling described
in the Training and Testing sections below.
Sampling of the Training Set Within the training set of patients, in
order to maximize amount of data represented in the model, all transitional
yi1 = 1 data was used. Each i1 patient was gender and age group matched
to a i0 patient from that specific gender and PELOD-2 criteria age group (eg.
Male and under 1 month old) uniformly randomly and without replacement
from the relevant i0 patients for one bootstrap iteration. If the length of data
in the non-transtional state of patient i1 was greater than half of the length
of transitional data, the y = 0 data was randomly sampled and evenly split
between patient i1 and patient i0, as shown in Figure 2.4. If the length of data
in the non-transitional state of patient i1 was less than the length of transitional
data in the same patient, another gender and age group matched i0 patient was
selected, and sampling of non-transitional state data was split evenly between
the two i0 patients (Figure 2.5). This sampling scheme designed in attempt to
add more contribution from i0 patients to the non-transitional state, since the
population of i0 was far larger than the i1, but still maintain a class balance in
number of samples between y = 0 and y = 1.
Each non-constant feature of the training set was normalized to mean 0 and
standard deviation 1 across all patients.
Testing Set The testing set contained the remaining 20% of the i1 patients
and all of the remaining i0 patients. The testing i1 patients were labeled with 2
hours of transitional data prior to t = Ti, the 2 hour no-sampling window from
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Patients who transition (N = 137) Patients always below transition thresold (N = 1877) p-value
Average PELOD-2 Score in patients Median (IQR, Range) 5.00 (2.00 to 7.00, 0.00 to 21.00) 2.00 (0.00 to 2.00, 0.00 to 5.00) <.0001
Length of PICU admission in patients (hr) 145.80 (70.20 to 344.90, 0.82 to 2898.00) 35.33 (21.50 to 64.69, 0.00 to 756.33) <.0001
First transition time (hours after admission) 2.77 (0.45 to 13.36, 0.02 to 958.05) NaN NaN
Score at first transition 7.00 (6.00 to 7.00, 6.00 to 8.00) NaN NaN
Increase in score amount at transition 3.00 (3.00 to 3.00, 2.00 to 5.00) NaN NaN
# occurences of score >0 (during transition or overall):
Neurological 119 32 <.0001
Cardiovascular 135 1260 <.0001
Renal 44 18 <.0001
Respiratory 137 149 <.0001
Hematalogical 68 157 <.0001
Table 2.2: Patient Organ Failure Distributions PELOD-2 Score and tran-
sition related distributions in patients containing the desired first transition
versus those who always remained below transition threshold.
t = Ti − 4h to t = Ti − 2h, and as non-transitional before time t = Ti − 4h.
yi(t) =
⎧⎪⎪⎪⎨⎪⎪⎪⎩
0 if t0 ≤ t < Ti − 4 · 60
NaN if Ti − 4 · 60 ≤ t < Ti − 2 · 60
1 if t ≤ Ti
(2.7)
Two normalization procedures were used in the testing set. The first method
represented a closer representation to real world application, where patients
would be individually normalized to standard normal distributions by each non-
constant feature. The second method normalized each non-constant feature
across all patients in the testing set.
Evaluation The global population GLM was evaluated in the same way
as the patient specific model in Equation 2.5, and sample by sample accuracy,
sensitivity, and specifity were calculated for training and testing sets at each
iteration. Early detection time was recorded and accuracy, sensitivity, and
specificity were calculated across patients to summarize the model performance




In this chapter, the important study cohort characteristics are summarized, and
then the patient specific model results are presented, followed by global model
results.
After applying the chosen definition of transitioning into a severe state,
where patients were admitted under a PELOD-2 Score of 5 and crossed this
threshold score, yielded 5.45% (N=137) PICU admissions for who transitioned
and 74.72% (N=1877) who remained below threshold for the entire duration of
their PICU stay. The median age of all patients was 5.4 years and ranged from
1 day to 18 years. 54.58% (N=1371) were male. Mortality rate was very low
1.25% (N=32). Other information on comorbidities are listed in Table 2.1.
The median PELOD-2 Score across the entire admissions of patients who
transitioned was 5 with a range of 0 to 21. In patients who never transitioned,
the median score was 2 with a range of 0 to 5. The median time of first transi-
tion was 2.77 hours with an interquartile range of <1 hour to 13.36 hours. This
distribution was right tailed, as the longest time of first transition after admis-
sion was nearly 18 days. Median length of PICU stay was significantly longer
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Figure 3.1: Training Set Statistics Accuracy, Sensitivity, and Specificity in
training sample time point comparisons of ŷi(t) to yi(t) across the 5 bootstrap
iterations per patient specific model without warnings. The x-axis represent
individual patients remaining after sampling and GLM criteria have been met
out of the 137 with the desired transition.
in patients who transitioned, at 145.8 hours (∼6 days, p<.05) while patients
who remained below transition threshold stayed for a median of 35.33 hours.
Individual organ failure presence in patients at transition in the case of those
falling within this criteria and presence in entire PICU stay in those who never
cross transition threshold are listed in Table 2.2.
3.1 Patient Specific Model
31 Patient admissions remained after patient selection criteria and further omis-
sion due to GLM warnings. There were 7 perfect separation warnings, 4 iter-
ation limit warnings, and 2 ill conditioned model warnings. Training model
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Figure 3.2: Testing Set Statistics Accuracy, Sensitivity, and Specificity in
testing seample time point comparisons of ŷi(t) to yi(t) across the 5 bootstrap
iterations per patient specific model without warnings.
performance by patient for comparing model prediction results by time point is
depicted in Figure 3.1. Testing performance is shown in Figure 3.2. Across these
31 patient specific models, the training accuracy, sensitivity and specificity was
91.57%±4.26%, 92.65%±5.28%, and 90.49%±6.27% respectively. The testing
accuracy, sensitivity, and specificity was 76.09%±11.24%, 95.16%±6.33%, and
73.09% ± 12.04% respectively.
Testing set performance on Figure 3.2 shows 8 individual patient models
with perfect specificity, meaning that for the times that the patients were in the
transitioning state, the decision the model made matched perfectly. However,
the specificity of these patients is not as high as in the training performance.
In Figure 3.3, there appeared to be an inverse correlation between length of
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Figure 3.3: Length of Data vs. Accuracy Accuracy of testing set according
to length of data in yi = 0 and yi = 1.
the yi = 0 state and accuracy of the models in the testing set. The Pearson
correlation for length of time in yi = 0 vs accuracy was ρ = −0.4553. When
omitting 2 cases of length of yi = 0 > 400 minutes, ρ = −0.7474. ρ = 0.3332
for the testing set correlation between yi = 1 and accuracy. The training set
showed no such correlation.
3.2 Global Model
The global model utilized as many patients containing transitions as possible.
Of the 137, 126 patients had data to sample yi1 = 1 from. There were 1851 i0
patients available for age group and gender matching. The number of patients
in each age group and gender are listed in Table 3.1.
The mean AUC of the ROC curve was 0.65 ranging from 0.61 to 0.70 across
50 iterations.
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i1 (N=126) i0 (N=1851)
<1 mo 14 37
1-12 mo 30 279
12-24 mo 9 143
24-60 mo 28 367
60-144 mo 23 499
144-216 mo 22 526
Male 66 1019
Table 3.1: Global Model Age and Gender
The mean ± standard deviation for time point performance for i0 patients,
shown in Figure 3.5(a), was 63.9% ± 1.36% in accuracy, 91.08% ± 6.64% in
sensitivity, and 21.87% ± 11.0% in specificity for the training set, and 11.95% ±
7.01%,92.67% ± 7.45%, and 11.91% ± 7.02% for the testing set. Figure 3.5(b)
shows the training and testing performance for patient wide detection, with both
training having 1.57% ± 2.86% accuracy and specificity, and 98.56% ± 1.99%
accuracy and specificity in the testing set.
The mean ± standard deviation for time point performance in i1 patients
is shown in Figure 3.7(a). Training accuracy, sensitivity, and specificity were
63.9% ± 1.36%, 91.08% ± 6.64%, and 21.87% ± 11.0% respectively. Testing
accuracy, sensitivity, and specificity were 13.68% ± 6.87%, 91.10% ± 6.62%,
and 12.05% ± 7.07% respectively. Figure 3.7(b) shows patient wide detection
statistics for i1 patients. Accuracy and sensitivity were both 98.41% ± 2.19% in
the training set, and 98.56% ± 1.99% in the testing set.
Using the method of normalizing each testing patient, the results were ex-
tremely close to normalizing across the entire testing set. The most substantial
difference in performance was that the i0 patients had an larger accuracy and
specificity, and smaller sensitivity in time point classification at 13.82%±7.01%
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Figure 3.4: ROC for Global Model The black lines represent the curves
with minimum, mean, and maximum, AUC across bootstrap iterations. The
blue shaded region represents where the ROC curves of other iterations lay.
accuracy, 79.65% ± 12.81% sensitivity, and 13.8% ± 7.02% specificity. The rest
of the exact performance statistics are listed in Appendix Table 5.1.
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(a) Time Point Classification (b) Patient-wide Detection
Figure 3.5: Performance Statistics for i0 Patients Training and testing set
accuracy, sensitivity, and specificity for patients who remain below transition
threshold for the entire duration of PICU stay.
Figure 3.6: Time Point Classification using per patient normalization
scheme on the testing set
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(a) Time Point Classification (b) Patient-wide Detection
Figure 3.7: Performance Statistics for i1 Patients Training and testing set
accuracy, sensitivity, and specificity for patients who meet transition criteria.
Figure 3.8: Coefficient Values Values for β obtained by the GLM. △ time




The complexity of MODS and its multiple and differing trajectories between
patients in combination with the low prevalence of high severity samples makes
computational model aided prediction a challenging task. This study provides
a basis for further research on detecting the risk of patients who may transition
into a severe state of multiple organ dysfunction. At the patient specific level,
building GLM based computational models for severity detection shows promise,
but improvements are necessary to make valid predictions on a more general
population level.
4.1 GLM and Computational Modeling
The patient specific model performance suggests that GLM can be used to
detect patients at risk of transitioning into severe states with organ failure at
a highly overtrained level, but at a global population level, the model used
in this study is lacking. In addition to the proposition mentioned above on
including different patient groupings from commorbidity and length of stay,
another point that could be improved upon is that criteria that was used to
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predict transitioning patients was a strict threshold, τ . From Figures 3.7 and
3.5, global model performance between patients who transition and patients
who do not was similar at a time point level, but the patient wide detection
showed a high tendency for the model to predict that patients are likely to
transition. Many of the patients who were always below transition threshold
were falsely detected as at risk using this strict threshold. Performance could
possibly increase if a moving average threshold or cumulative risk score over a
small window was implemented in the case of spikes in ŷ, risk. However, at a
cursory glance when plotting the ŷ across patients, many patients had longer
periods where ŷ remains above τ .
Crone and Finlay [32] analyzed the effect of heterogeneous variations in large
datasets on the performance of a classifying imbalanced classes using logistic
regression, linear discriminant analysis, classification and regression trees, and
neural networks. Three situations were considered: the over or under sampling
method of balancing contribution from a binary classification problem, slowly
incrementing class imbalance because the inherent population is imbalanced,
and a combination of the sample size and balancing considerations. Logistic
regression was found to have no benefit from artificially balancing the samples,
and benefitted from using all data avialable [32].
Similarly, an experiment using ISOLET speech data, which contains various
subjects enunciating letters of the alphabet from the University of California
Irvine Machine Learning Repository, varied the prevalence of a target letter of
the alphabet and compared regularized logistic regression, random forest, and
soft-margin support vector machine model performance [33]. Accuracy, posi-
tive predictive value (PPV), sensitivity, and specificity were evaluated on each
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model with training prevelence varying from above 0 to 0.5. Accuracy, PPV, and
specificity decreased, and sensitivity increased. The elements of speech recog-
nition have much better precedence and model performance than the modeling
of organ failure in this study. Therefore, seeing the change in performance of a
well known logistic regression based classfier due to artificially increasing preva-
lence of the positive class suggests that the method of undersampling and class
balancing in this study needs to be adjusted.
In line with this analysis of prevelence of positive class in the training data,
the accuracy of the patient specific models decreased when patients with longer
lengths of pre-transitioning data are artificially downsampled (Figure 3.3). Lo-
gistic regression finds the optimal set of coefficients which minimize deviance
according to the distribution of the training data, and is the specific type of
generalized linear model that uses logit link function used in this study. Thus,
it makes sense that downsampling from the y = 0 class led to a large sensitivity
in the results and extremely low specificity. The number of patients who never
transition outweighed the number of patients who do transition by nearly 16
times, and the window of transitioning time was a mere 2 hours compared to
median length of stay at over 24 hours.
4.2 Clinically related factors and MODS Phys-
iology
The models evaluated in this study used PELOD-2 to define the difference be-
tween a low risk and a patient at risk of severe organ dysfunction. However, the
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ACCP/SCCM Consensus Conference Committee outlined two different path-
ways to MODS, where primary MODS occurs early, directly after an insult to
the organs involved, and secondary MODS as a later response to some other
inciting injury such as systemic inflamation response syndrome or sepsis [22].
The two pathways for MODS physiology suggest that it may be helpful to strat-
ify patients into two groups depending on duration of PICU stay or time when
transition occurs.
Proulx et al. [34] used the differentiation of primary MODS if patients had
MODS at PICU admission, and secondary MODS if patients developed MODS
during the first week after admission or later. Using this critera, Proulx et al. [1]
and Tantaleán et al. [2] found the majority of the pediatric MODS patients as
having primary MODS at 84.6% and 86% respectively. Similarly, the majority
of patients in this study transitioned within 12 hours of PICU admission (the
3rd quartile for first transition time was 13.36 hours after admission).
Another consideration that could be further investigated are commorbidities;
Bestati et al. [5] suggests that congenital cardiac disease may contribute to
high hazard ratio related to cardiac dysfunction in neonates. It may be worth
clustering patients by presence of commorbidities such as congenital diseases or
surgical operations.
The β values in Figure 4.1 are trained from individual patients and too
specific for comparison to the global population values, where interpretation of
β is also dependent on age group and gender, but the variation between and
within patients may reveal information with future further analysis on the above
mentioned physiologically related factors and comorbidities.
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(a) Constant
(b) Heart Rate (c) Mean Arterial Pressure
(d) Systolic Blood Pressure (e) Diastolic Blood Pressure
(f) Respiration Rate (g) Pulse Oximetry
Figure 4.1: Patient Specific Coefficient Values Values for β obtained by
the GLM.
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4.3 PELOD-2 Related Outcomes
The definition for severity defined in this study relied on the variables mean
arterial pressure and presence of invasive ventilation that had high enough fre-
quency to mark the transition with some confidence. This noticeably limited
the types of patients used for modeling, and in the future, data sets with more
regularly measured variables would be beneficial to early detection studies. In
Table 2.2, the presence of individual organ PELOD-2 scores above zero during
a desired transition are tallied. All of the selected patients who contain transi-
tions have respiratory organ failure, and all but two of them have cardiovascular
failure. This is expected from only relying on transitions caused by mean arte-
rial pressure or invasive ventilation. There was also a fairly high number 119
(87%) of the 137 who had at least a score of 1 in neurological organ failure.
Although, in the PELOD-2 score, GCS and pupillary reaction are the defining
factors of neurologic organ dysfunction, GCS is the main source contributing
to the score. The data obtained from EHR on pupil movement and dilation
was highly sparse, with only a handful of patients from the entire 2512 patients
containing information involving both pupils being simultaneously fixed and
dilated.
The older PELOD score was found to be a significant prognostic factor for
death [35], but the patients in the Leteurtre study were stratified into three
categories of day 1 PELOD scores: <10, 10-19, and ≥ 20. Even the lowest
score category included patients beyond what was considered severe in this
study. An earlier model was built to classify the extreme transition in this
study cohort, where selected patients were admitted below a PELOD-2 score of
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5 and transitioned to a score ≥ 20. Perfect separation was achieved on the 2
patients under this criteria, without implementing the transitional window and
purely classifying time points on training data. The definition of severity may
use further exploration to achieve better model results, however the challenge to
this is that more stringent transition definitions are likely to reduce the number
of patients labeled with a transition.
Suggestions for further study include varying class balancing schemes to
find the optimal method of sampling, testing other definitions of severity which
incorporate other physiological factors of what is known about the progression
of MODS, and varying the length of the transitional window. Calibration of
these model definitions may lead to a model that is performs well across the
general PICU population and can aid physician early diagnoses.
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5.1 Figures and Tables
Figure 5.1: Frequency of Physiological Variables Example of variable
frequency occuring in one patient. The x-axis represents difference in time from
previous data sample or start of data collection. The y-axis represents histogram
count of how many occurences this interval is present. The top two quadrants
shows entire patient admission time and the bottom shows up to first transition
time only. Opacity of the bars is lowered to show that bars are overlapped, not
stacked.
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Figure 5.2: Example GLM iterations of the patient specific models.
Time Point Classification Patient Detection
Accuracy Sensitivity Specificity Accuracy Sensitivity Specificity
i1 Patients Training 63.91% ± 1.36% 91.15% ± 6.69% 21.73% ± 11.09% 98.39% ± 2.18% 98.39% ± 2.18% -Testing 15.47% ± 6.89% 90.92% ± 6.70% 13.9% ± 7.07% 98.52% ± 1.97% 98.52% ± 1.97% -
i0 Patients Training 63.91% ± 1.36% 91.15% ± 6.69% 21.73% ± 11.09% 1.57% ± 2.86% - 1.57% ± 2.86%Testing 13.82% ± 7.01% 79.65% ± 12.81% 13.8% ± 7.02% 0.2% ± 0.08% - 0.2% ± 0.08%
Table 5.1: Global Model Performance Statistics using per patient normal-
ization on the testing set
5.2 Data Processing
5.2.1 PELOD-2 Variables
Glasgow Coma Score values were invalidated during all time points between
recorded administrations of one unique sedative. The list of sedatives was:
Dexmedetomidine, Fentanyl, Hydromorphone, Ketamine, Midazolam, Morphine,
Propofol, Remifentanil.
Pupils were only marked as fixed and dilated (needed for the Leteurtre et al.
[8] PELOD-2 definition) if both pupils contained information indicating that,
within a time interval up to and including 5 minutes, both pupils were ≥ 3 mm
as well as non-reactive or fixed. In logic notation, documentation of each pupil
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within 5 minutes must say:
left pupil: ≥ 3 mm AND (fixed or non-reactive)
AND
right pupil: ≥ 3mm AND (fixed or non-reactive)
for pupils to contribute the PELOD-2 score. Time points with indications of
chemical dilation by Opthamology were discarded.
Mean arterial pressure was taken from non-invasive measurements first, and
then arterial measurements if non-invasive measurements were missing. Addi-
tionally, arterial MAP was counted as missing if values exceeded 120 mmhg.
PaO2/FiO2 ratio was calculated from the measurements within 1 hour of
each other, order of measurement was disregarded. In the case that more than
one measurement existed within this acceptable window, PaO2/FiO2 was calcu-
lated using the values that would give the most severe value to the ratio. The
time of the first measured value in the ratio was assigned to the PaO2/FiO2
ratio.
Mechanical or invasive ventilation was identified by a list of strings recorded
in EHR flowsheet data. After positively identifying a patient on mechanical
ventilation, the status was held for every minute up to an hour or until the
next identifier occurred. Non-invasive ventilation was also identified, so times
where both methods were supposedly present were removed for any mode of
ventilation due to the uncertainty.
The PELOD-2 score was calculated following Leteurtre et al. [8]. A sliding
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window of 24 hours was implemented, and the PELOD-2 score was assigned
based on the sum of scores determined using the worst values taken for each
variable within the previous 24 hours. The 24 hour sliding windows began with
one timepoint at the start of patient data availability, and expanded up until
the full 24 hours so a PELOD-2 score existed for all times when data existed
for a patient.The time of the score was assigned to the last time point existing
within a window. If no data were available for a particular variable within the
prior 24 hours, a score of 0 (normal) was assigned for that variable. If a variable
was measured more than once in the prior 24 hours, the worst value was used
in calculating the score.
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